Teleflex Incorporated (NYSE:TFX) Q4 2023 Earnings Call Transcript

Mike Matson : And then just on you are within China, I know you talked about the size there, and obviously, there’s a ton of people there. But can you just talk about kind of the competitive landscape? And then I’m not even sure whether this is something that’s covered by government payers, insurance or is it something that’s out of pocket for these BPH treatments there?

Liam Kelly : Yes. So the landscape is similar to where it is everywhere else in so far is that Tarp is the main procedure that is used on men within China. The nuance in China is that they don’t tend to be as pharma focused in so far as that they will try other herbal remedies within that. But you’re right, it’s such a huge population. The way it works within China is your first step is to get it listed on all of the regional tenders. So we’re going through that process now in Shanghai and Beijing, in those 2 big provinces. That would be an obvious place to start. And then thereafter, you apply for reimbursement. The reimbursement never covers in any procedure of the total cost of the procedure, Mike, there’s always some out-of-pocket and the general population in China is used to have to pay out-of-pocket when they go to a hospital.

Operator: I would now like to turn the call over to Mr. Lawrence Keusch for closing remarks.

Lawrence Keusch: Thank you, [Mandeep] and thank you to everyone that joined us on the call today. This concludes the Teleflex Incorporated fourth quarter 2023 earnings conference call.

Operator: That is all the time we have for questions this morning. Our conference for today is now concluded. Thank you all for your participation.